ASN​ 2025 6 - 9 November 2025

Kidney, cardiovascular, and death outcomes with semaglutide treatment among two race and two ethnic groups: post hoc analysis from the FLOW trial

Authors :

Carlos Campos, MD1; Richard Pratley, MD2; Katherine Tuttle, MD3; Sherif Mehanna, MD, MBS4; Caroline Swift, PhD, MPH4; Søren Rasmussen, PhD5; Peter Rossing, DMSc, MD6; Vlado Perkovic, PhD7; Kenneth Mahaffey, MD8; Christian Mende, MD9

Affiliations
View Details Hide Details
Download poster (.pdf)
Keywords
Diabetes
Congress poster
GLP-1 RA
Semaglutide
Other